Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review

Current evidence suggests that higher baseline HbA1c is associated with a greater efficacy of both DPP-4I and GLP-1A therapies in lowering HbA1c. The roles of other potential predictors are less consistent across studies and require further investigation.